Robert Michael  Floyd net worth and biography

Robert Floyd Biography and Net Worth

Founder of Exbaq LLC and Elion Oncology, Inc., R. Michael Floyd presently occupies the position of Chief Operating Officer for Processa Pharmaceuticals, Inc.

He previously held the position of President, Chief Executive Officer & Director at Elion Oncology, Inc. and Chief Executive Officer-North America at Evolva Holding SA.

He received an undergraduate degree from Georgetown University.

What is Robert Michael Floyd's net worth?

The estimated net worth of Robert Michael Floyd is at least $3,220.00 as of June 22nd, 2021. Mr. Floyd owns 1,400 shares of Processa Pharmaceuticals stock worth more than $3,220 as of March 28th. This net worth approximation does not reflect any other assets that Mr. Floyd may own. Learn More about Robert Michael Floyd's net worth.

How do I contact Robert Michael Floyd?

The corporate mailing address for Mr. Floyd and other Processa Pharmaceuticals executives is 7380 COCA COLA DRIVE SUITE 106, HANOVER MD, 21076. Processa Pharmaceuticals can also be reached via phone at (443) 776-3133 and via email at [email protected]. Learn More on Robert Michael Floyd's contact information.

Has Robert Michael Floyd been buying or selling shares of Processa Pharmaceuticals?

Robert Michael Floyd has not been actively trading shares of Processa Pharmaceuticals within the last three months. Most recently, on Tuesday, June 22nd, Robert Michael Floyd bought 100 shares of Processa Pharmaceuticals stock. The stock was acquired at an average cost of $140.60 per share, with a total value of $14,060.00. Following the completion of the transaction, the chief operating officer now directly owns 1,400 shares of the company's stock, valued at $196,840. Learn More on Robert Michael Floyd's trading history.

Who are Processa Pharmaceuticals' active insiders?

Processa Pharmaceuticals' insider roster includes Robert Floyd (COO), Patrick Lin (Insider), James Stanker (CFO), Justin Yorke (Director), and David Young (CEO). Learn More on Processa Pharmaceuticals' active insiders.

Are insiders buying or selling shares of Processa Pharmaceuticals?

During the last year, Processa Pharmaceuticals insiders bought shares 7 times. They purchased a total of 45,500 shares worth more than $157,895.00. The most recent insider tranaction occured on February, 7th when insider David Young bought 21,000 shares worth more than $51,450.00. Insiders at Processa Pharmaceuticals own 22.2% of the company. Learn More about insider trades at Processa Pharmaceuticals.

Information on this page was last updated on 2/7/2024.

Robert Michael Floyd Insider Trading History at Processa Pharmaceuticals

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/22/2021Buy100$140.60$14,060.001,400View SEC Filing Icon  
See Full Table

Robert Michael Floyd Buying and Selling Activity at Processa Pharmaceuticals

This chart shows Robert Michael Floyd's buying and selling at Processa Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Processa Pharmaceuticals Company Overview

Processa Pharmaceuticals logo
Processa Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on developing the chemotherapy drugs to improve the safety and efficacy of cancer treatment. Its drugs are modifications of existing FDA-approved oncology drugs resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms of killing the cancer cells. Its pipeline includes three Chemotherapy drugs, including Capecitabine, PCS6422 and capecitabine to treat metastatic colorectal, gastrointestinal, breast, pancreatic, and other cancers; Gemcitabine, PCS3117 to treat pancreatic, lung, ovarian, breast, and other cancers; and Irinotecan, PCS11T to treat lung, colorectal, gastrointestinal, pancreatic, and other cancers. Processa Pharmaceuticals, Inc. was incorporated in 2011 and is based in Hanover, Maryland.
Read More

Today's Range

Now: $2.30
Low: $2.27
High: $2.40

50 Day Range

MA: $2.50
Low: $2.05
High: $5.10

2 Week Range

Now: $2.30
Low: $2.02
High: $18.00

Volume

29,768 shs

Average Volume

1,581,924 shs

Market Capitalization

$2.83 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.53